Denver Wealth Management Inc. Sells 163 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI)

Denver Wealth Management Inc. trimmed its stake in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 1.1% during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 14,616 shares of the exchange traded fund’s stock after selling 163 shares during the period. SPDR S&P Biotech ETF accounts for about 0.6% of Denver Wealth Management Inc.’s investment portfolio, making the stock its 25th largest position. Denver Wealth Management Inc.’s holdings in SPDR S&P Biotech ETF were worth $1,316,000 as of its most recent filing with the SEC.

Other institutional investors have also made changes to their positions in the company. FMR LLC raised its stake in shares of SPDR S&P Biotech ETF by 13.6% in the 3rd quarter. FMR LLC now owns 6,940 shares of the exchange traded fund’s stock valued at $686,000 after acquiring an additional 830 shares in the last quarter. Ameritas Advisory Services LLC increased its position in SPDR S&P Biotech ETF by 11.9% in the 4th quarter. Ameritas Advisory Services LLC now owns 10,684 shares of the exchange traded fund’s stock worth $962,000 after buying an additional 1,137 shares during the period. Beaton Management Co. Inc. bought a new position in SPDR S&P Biotech ETF in the 3rd quarter worth approximately $212,000. Robinson Value Management Ltd. increased its position in SPDR S&P Biotech ETF by 1.2% in the 3rd quarter. Robinson Value Management Ltd. now owns 13,452 shares of the exchange traded fund’s stock worth $1,329,000 after buying an additional 155 shares during the period. Finally, Granite Bay Wealth Management LLC increased its position in SPDR S&P Biotech ETF by 4,965.8% in the 2nd quarter. Granite Bay Wealth Management LLC now owns 124,062 shares of the exchange traded fund’s stock worth $11,097,000 after buying an additional 121,613 shares during the period.

SPDR S&P Biotech ETF Stock Up 0.6 %

Shares of NYSEARCA XBI opened at $93.18 on Wednesday. The business’s 50 day moving average is $93.35 and its two-hundred day moving average is $96.83. The company has a market cap of $7.10 billion, a P/E ratio of 11.47 and a beta of 1.11. SPDR S&P Biotech ETF has a 12 month low of $81.14 and a 12 month high of $105.47.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.